Theranos' Holmes admits she slapped Big Pharma logos on lab reports to boost her biz

'I wish I had done it differently' she tells jury in fraud trial

Theranos boss Elizabeth Holmes admitted in court this week she personally added Pfizer and Schering-Plough logos to her startup's presentations while trying to seal a deal with Walgreens.

Giving testimony on Tuesday during her fraud trial, the one-time chief exec damningly revealed it was her idea to place the pair of Big Pharma logos on Theranos reports and then send them to Walgreens executives.

Holmes is battling charges she defrauded, and conspired to defraud, investors out of hundreds of millions of dollars by grossly exaggerating the abilities of her company's technology.

Here's the lead up to this admission: Pfizer and Schering-Plough produced due-diligence reports on Theranos for the now-imploded startup. Theranos staff took those documents and then created their own lab reports boasting about the supposed efficacy of their blood-testing machines. These files, adorned with Pfizer and Schering-Plough logos seemingly to give them credibility, were then shared with investors and the top-brass at US drugstore chain Walgreens.

But staff at Pfizer and Schering-Plough testified Theranos had no right to use the logos, and they weren't even aware the logos were being used in this way. It's also said the two pharmaceutical giants disagreed with the final reports Theranos produced, and distanced themselves from the upstart.

Now Holmes has told a jury she added the logos due to her company's earlier relationship with Pfizer and Schering-Plough, and claimed she did not do this to trick anyone into thinking the pair had endorsed the lab reports.

"This work was done in partnership with those companies and I was trying to convey that," she said, NBC reported, adding: "I wish I had done it differently."

Holmes said the document augmentation took place to win a contract to provide blood testing services at Walgreens. She also admitted those blood tests weren't actually done with Theranos hardware but with modified commercially available testing equipment.

Holmes said a high demand for testing forced her company to move from in-store testing to a centralized laboratory facility where the third-party systems were installed. She said the commercial blood testers had been modified and optimized by Theranos to use less blood for testing and she couldn't tell that to her investors because it was a trade secret.

Holmes said she was concerned that if the manufacturers of the equipment knew how Theranos had altered their devices they could have reverse engineered the technology and sold it themselves. She insisted she had not misled investors and her business partners by withholding the truth about Theranos's testing regime, that it was using off-the-shelf equipment rather than its own machinery.

Her defense brought up an email exchange between Holmes and Theranos's then chief scientist Ian Gibbons discussing the progress on the startup's own blood-testing hardware. “Our immunoassays match the best that can be done in clinical labs and work with small blood samples. Generally our assays are faster by a factor of three to 10 than kits,” Gibbons wrote.

Holmes testified she took this to mean her products could actually work as advertised. But, as has been previously claimed, Theranos hardware was wildly inaccurate, being wrong more than 51 per cent of the time. The full picture may never be known as the company's test result database was mysteriously lost in 2018.

Holmes, who denies any wrongdoing, faces two counts of conspiracy to commit wire fraud and nine counts of wire fraud. Her trial continues. ®

Similar topics

Broader topics

Other stories you might like

  • India reveals home-grown server that won't worry the leading edge

    And a National Blockchain Strategy that calls for gov to host BaaS

    India's government has revealed a home-grown server design that is unlikely to threaten the pacesetters of high tech, but (it hopes) will attract domestic buyers and manufacturers and help to kickstart the nation's hardware industry.

    The "Rudra" design is a two-socket server that can run Intel's Cascade Lake Xeons. The machines are offered in 1U or 2U form factors, each at half-width. A pair of GPUs can be equipped, as can DDR4 RAM.

    Cascade Lake emerged in 2019 and has since been superseded by the Ice Lake architecture launched in April 2021. Indian authorities know Rudra is off the pace, and said a new design capable of supporting four GPUs is already in the works with a reveal planned for June 2022.

    Continue reading
  • Prisons transcribe private phone calls with inmates using speech-to-text AI

    Plus: A drug designed by machine learning algorithms to treat liver disease reaches human clinical trials and more

    In brief Prisons around the US are installing AI speech-to-text models to automatically transcribe conversations with inmates during their phone calls.

    A series of contracts and emails from eight different states revealed how Verus, an AI application developed by LEO Technologies and based on a speech-to-text system offered by Amazon, was used to eavesdrop on prisoners’ phone calls.

    In a sales pitch, LEO’s CEO James Sexton told officials working for a jail in Cook County, Illinois, that one of its customers in Calhoun County, Alabama, uses the software to protect prisons from getting sued, according to an investigation by the Thomson Reuters Foundation.

    Continue reading
  • Battlefield 2042: Please don't be the death knell of the franchise, please don't be the death knell of the franchise

    Another terrible launch, but DICE is already working on improvements

    The RPG Greetings, traveller, and welcome back to The Register Plays Games, our monthly gaming column. Since the last edition on New World, we hit level cap and the "endgame". Around this time, item duping exploits became rife and every attempt Amazon Games made to fix it just broke something else. The post-level 60 "watermark" system for gear drops is also infuriating and tedious, but not something we were able to address in the column. So bear these things in mind if you were ever tempted. On that note, it's time to look at another newly released shit show – Battlefield 2042.

    I wanted to love Battlefield 2042, I really did. After the bum note of the first-person shooter (FPS) franchise's return to Second World War theatres with Battlefield V (2018), I stupidly assumed the next entry from EA-owned Swedish developer DICE would be a return to form. I was wrong.

    The multiplayer military FPS market is dominated by two forces: Activision's Call of Duty (COD) series and EA's Battlefield. Fans of each franchise are loyal to the point of zealotry with little crossover between player bases. Here's where I stand: COD jumped the shark with Modern Warfare 2 in 2009. It's flip-flopped from WW2 to present-day combat and back again, tried sci-fi, and even the Battle Royale trend with the free-to-play Call of Duty: Warzone (2020), which has been thoroughly ruined by hackers and developer inaction.

    Continue reading

Biting the hand that feeds IT © 1998–2021